Fleroxacin uptake in ischaemic limb tissue

Acta Microbiologica et Immunologica Hungarica

Volumn 48, Issue 1, 2001, Pages 11-15

  Miglioli, P A ^a   Kafka, R ^a   Bonatti, H ^a   Fraedrich, G ^a   Allerberger, F ^a   Schoeffel, U ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antibiotic therapy; Fleroxacin; Ischaemic tissues

Indexed keywords

NEGIBACTERIA; POSIBACTERIA;

ANTIINFECTIVE AGENT; FLEROXACIN;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BLOOD; BONE; DIFFUSION; FEMALE; ISCHEMIA; LIMB; MALE; METABOLISM; SHEEP; SKELETAL MUSCLE; TENDON;

ADIPOSE TISSUE; ANIMALS; ANTI-INFECTIVE AGENTS; BONE AND BONES; DIFFUSION; EXTREMITIES; FEMALE; FLEROXACIN; ISCHEMIA; MALE; MUSCLE, SKELETAL; SHEEP; TENDONS;

EID: 0041829204     PISSN: 12178950     EISSN: None     Source Type: Journal    
DOI: 10.1556/AMicr.48.2001.1.2     Document Type: Article

References (11)

1. Kerin, M.J., Sheehan, S.J., Greenstein, D., Kester, R.C., Chisholm, E.M.: Is antibiotic penetration compromised in the ischaemic tissues of patients undergoing amputation? Annals of the Royal College of Surgeons of England 74, 274 (1992).
2. Bullen, B.R., Ramsden, C.H., Kester, R.C.: Cefuroxime levels attained in tissues and wound exudates from severely ischaemic limbs. J Chemother 7, 163 (1981).
3. Balfour, J.A., Todd, P.A., Peters, D.H.: Fleroxacin, a review of its pharmacology and therapeutic efficacy in various infections. Drugs 49(5), 794 (1995).
4. Weidekamm, E., Portmann, R.: Penetration of fleroxacin into body tissues and fluids. The American J Medicine, 94(suppl3A), 3A-75S (1993).
5. Griggs, D.J., Wise, R.A.: Simple isocratic high-pressure liquid chromatographic assay of quinolones in serum. J Antimicrob Chemother 24, 437 (1989).
6. Wise, R., Kirkpatrick, B., Ashby, J., Griggs, D.J.: Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone. Antimicrob Agents Chemother 31(2), 161 (1987).
7. Auckenthaler, R., Waldvogel, F.A.: Bone and synovial fluid. In Ristuccia, A.M., Chuna, B.A. (eds): Antimicrobial therapy. Raven Press, New York Raven Press, 1984. pp. 505-512.
8. Rubin, R.H., Livni, E., Babich, J., Alpert, N.M., et al.: Pharmacokinetics of fleroxacin as studied by positron emission tomography and fleroxacin. The American J Medicine 94(suppl3A), 3A-31S (1993).
9. Gerding, D.N., Hugeshes, C.E., Bamberger, D.M., Foxworth, J., Larson, T.A.: Extravascular antimicrobial distribution and the respective blood concentrations in humans. In Lorian, V. (ed.): Antibiotics in laboratory medicine. 4th ed. Williams and Wilkins publisher, Baltimore, Maryland. 21201-2436 USA, 1996. pp. 862-865.
10. Reigner, B.G., Welker, H.A.: Factors influencing elimination and distribution of fleroxacin: metaanalysis of individual data from 10 pharmacokinetic studies. Antimicrob Agents Chemother 40(3), 575 (1996).
11. NCCLS. Performance Standards for Antimicrobial Susceptibility Testing; Eight Informational Supplement. NCCCLS document M100-S8(ISBN 1-56238-337-X). NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 1998.